Arthritis drug Celecoxib also fights breast cancer
May 6, 2011
A new study presented at the IMPAKT Breast Cancer Conference held in Brussels suggests that the drug celecoxib, used for arthritis, has beneficial effects against breast cancer as well, according to the Daily India.
"This is exciting because it means that a medication already used to treat other diseases may be efficient in the adjuvant treatment of breast cancer as well," said principal researcher Juergen Veeck at Maastricht University Medical Center in The Netherlands.
Veeck says that the drug works as a COX-2 inhibitor, which also affects cell growth, cell death and the extracellular matrix of primary breast cancer tissues.
One in eight women in the U.S. is diagnosed with breast cancer in her lifetime, according to the American Cancer Society. More than 200,000 women were newly diagnosed with breast cancer in 2010.
According to the American Cancer Society, women over the age of 40 should receive yearly mammograms. Many minority women are also highly susceptible to breast cancer in their 40s.
For the upcoming Mother's Day holiday, women should remind themselves and their loved ones to receive mammograms and other breast exams in order to catch the illness at its earliest onset.